The contracts, worth a total of approximately $1.15m, are expected to be delivered over the next 24 months with the majority to be delivered within the next 12 months.
Kromek’s detector modules will be incorporated into the OEMs’ systems to produce some of the most accurate imaging to diagnose the strength and health of bones. The systems will allow clinicians to accurately detect and monitor progression of osteoporosis in patients resulting in more effective treatment.
Dr Arnab Basu, CEO of Kromek, said: "It is very pleasing to secure double the orders we received from these long-standing customers last year. It strengthens our relationship with them and further validates our belief that more and more legacy detection systems are being replaced with BMD diagnostic systems with our CZT detectors. The agreements represent the continued healthy conversion of our pipeline into orders as we continue to win new contracts in the medical sector."
The Group’s products provide high resolution information on material composition and structure and are used in multiple applications, ranging from the identification of cancerous tissues to hazardous materials, such as explosives, and the analysis of radioactive materials.